Research programme: PLA2G6 associated neurodegeneration therapeutics - Apteeus
Latest Information Update: 13 Oct 2023
At a glance
- Originator APTEEUS
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Neurodegenerative disorders
Most Recent Events
- 25 Sep 2023 Early research in Neurodegenerative disorders in France (unspecified route) prior to September 2023 (Apteeus pipeline, September 2023)